Find clinical trials for bladder cancer. Search for bladder cancer clinical trials in different cities and states across the United States.
Filter
1
Filter results
Results: 219
Active & ResponsiveNew
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
for
NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC),
Location: 3 recruiting locations
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07277413
Phase1, Recruiting
Active & Responsive
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
for
Non-Muscle Invasive Bladder Cancer
Location: 6 recruiting locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06637423
Phase1, Phase2, Recruiting
Active & Responsive
Improving Care for Rural Patients With Solid Tumors
for
Lung Cancer, Head and Neck Cancer, Thyroid Cancer,
Location: 11 recruiting locations
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 70+
Code: NCT04916990
Recruiting
Active & Responsive
Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)
for
Bladder Cancer, Muscle-Invasive Bladder Carcinoma
Location: 1 recruiting location
Sponsor: Columbia University
Sex: All
Age: 18+
Code: NCT06571708
Phase2, Recruiting
Active & Responsive
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
for
Bladder Cancer, Breast Cancer, Colon Cancer, Endometrial Cancer,
Location: 1 recruiting location
Sponsor: University of California, San Francisco
Sex: All
Age: 18+
Code: NCT05056077
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
for
Localized Renal Pelvis and Ureter Urothelial Carcinoma,
Location: 1 recruiting location
Sponsor: University of Washington
Sex: Male
Age: 18+
Code: NCT01050504
Recruiting
Active & Responsive
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
for
Solid Tumor Malignancies, Colorectal Carcinoma,
Location: 9 recruiting locations
Sponsor: Tasca Therapeutics
Sex: All
Age: 18+
Code: NCT07030257
Phase1, Phase2, Recruiting
Active & Responsive
Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy